Responses
Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
957 The ATR-inhibitor ceralasertib modulates the tumor microenvironment and improves the effect of anti-PDL1 by activating type I IFN pathway
Compose a Response to This Article
Other responses
No responses have been published for this article.
